Table: Torii Pharmaceutical - 9-MTH parent results
Oct 26 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2017 Sep 30, 2016 Dec 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 45.73 43.77 63.10
(+4.5 pct) (-2.4 pct) (+4.8 pct)
Operating 3.66 2.57 5.00
(+42.2 pct) (-26.3 pct) (+30.9 pct)
Recurring 3.74 2.71 5.10
(+37.6 pct) (-26.0 pct) (+27.5 pct)
Net 2.77 1.76 3.80
(+57.9 pct) (-24.7 pct) (+33.8 pct)
EPS 98.83 yen 62.04 yen 135.48 yen
Ann Div 48.00 yen 48.00 yen
-Q2 div 24.00 yen 24.00 yen
-Q4 div 24.00 yen 24.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)